A public feud over model originality threatens China’s collaborative AI front, with Huawei denying whistleblower claims of ...

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Apple's head of AI models, Ruoming Pang is set to quit the company to join Meta to lead its new AI superintelligence division ...

NOAA will be collaborating with Google's DeepMind and will evaluate the new models and provide feedback to Google's AI ...

Imagine a world without disease. Sounds utopian? AI just made it a multibillion-dollar bet to discover drugs – and forget Big ...

Isomorphic Labs advances towards human clinical trials for AI-designed drugs, marking a pivotal moment in pharmaceutical ...

For a company long defined by proprietary development, this move is a symbol of a broader technological undercurrent sweeping ...

Ruoming Pang previously ran Apple's in-house team that trained the AI foundation models that underpin Apple Intelligence and ...

The decision to end the service was ultimately made by the US Department of Defense (DoD) and affects data collected by the ...

Computers can help ensure that mathematical proofs are correct, but translating traditional maths into a machine-readable ...

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...